Genentech ordered to stop misleading promotions

The FDA recently sent a letter to Genentech ordering it to alter the promotion of its Nutropin growth hormone. Labels for the hormone do not advise consumers of potentially dangerous side effects of the product. Separately, Genentech and Amgen settled a long-standing patent dispute over drugs used to fight infections in cancer patients.

View Full Article in: · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Food & Beverage

Job Title Company Location
Culinary Management Training Program
HIllstone Restaurant Group
Multiple Locations, SL_Multiple Locations
Staff Assistant, Executive Sous Chef
University of Massachusetts Amherst
Amherst, MA
Adjunct Instructor - Ancient Foods in the Modern World
The Culinary Institute of America
San Antonio, TX
Adjunct Instructor - Menu Development
The Culinary Institute of America
San Antonio, TX
Culinary Arts Chef Instructor
The Culinary Institute of America